- Home
- PFG vs ICLR Comparison
PFG vs ICLR Comparison
Compare PFG & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFG | ICLR |
|---|---|---|
| Founded | 1879 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.6B | 15.1B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | PFG | ICLR |
|---|---|---|
| Price | $90.42 | $184.15 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 14 |
| Target Price | $90.20 | ★ $201.46 |
| AVG Volume (30 Days) | ★ 1.2M | 917.5K |
| Earning Date | 02-09-2026 | 02-18-2026 |
| Dividend Yield | ★ 3.50% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 6.91 | ★ 7.47 |
| Revenue | ★ $15,800,800,000.00 | $8,102,602,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.78 | $0.66 |
| P/E Ratio | ★ $13.06 | $24.27 |
| Revenue Growth | ★ 12.33 | N/A |
| 52 Week Low | $68.39 | $125.10 |
| 52 Week High | $92.51 | $220.93 |
Technical Indicators
Market Signals| Indicator | PFG | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 57.98 | 48.48 |
| Support Level | $87.60 | $171.99 |
| Resistance Level | $92.51 | $203.91 |
| Average True Range (ATR) | 1.47 | 6.70 |
| MACD | -0.02 | 0.22 |
| Stochastic Oscillator | 58.86 | 34.77 |
Price Performance
Historical ComparisonAbout PFG Principal Financial Group Inc
Principal Financial Group Inc is a financial services provider. It offers various financial products and services including retirement, asset management, and workplace benefits and protection solutions to individuals and institutional clients. The company, along with its subsidiaries, operates in the following reportable segments; Retirement and Income Solutions, Principal Asset Management, and Benefits and Protection. Maximum revenue is generated from the Retirement and Income Solutions segment which provides workplace savings and retirement solutions, banking, trust and custodial services, individual variable annuities (including RILAs), pension risk transfer, and investment services to businesses, their employees, and other individuals.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.